CRS Clinical Research Services Mannheim GmbH — Clinical Trial Site

12 Registered trials

3 Currently recruiting

Organisation

CRS Clinical Research Services Mannheim GmbH

Location

Mannheim, Germany

Identifier

ORG-100012881

Address

Grenadierstrasse 1, Neckarstadt, 68167, Germany

Departments

Clinic
Clinical Pharmacology Unit
Clinical Research Services | Clinical Research Services Mannheim - Phase one unit
Clinical Unit
Clinincal Pharmacology Unit
CRS Clinical Research Services Mannheim GmbH
N/A
NA

Clinical trials at this site (12)

Search interface

Bioequivalence study of the oral suspension of netupitant/palonosetron combination product versus the hard capsules of netupitant/palonosetr… Not authorised

2023-504355-28-00 Healthy volunteers 2
A study to learn how safe nurandociguat is when taken with sildenafil in men with arterial hypertension. Pending

2025-522336-14-00 Chronic Kidney Disease 3
Chlorhexidine and/or metronidazole plus FB301 pre-treatment trial Recruiting

2025-524362-20-00 Bacterial vaginosis 4 2026-03-23
A clinical trial investigating the safety and biological activity of the antibody BNT351 in adults living without and with HIV Recruiting

2025-523846-29-00 HIV-1 infection 1 2026-02-09
Pharmacokinetics, pharmacodynamics, safety, and tolerability of an acetonic milk thistle extract, standardized to silymarin, in subjects wit… Recruiting

2025-522423-95-00 chronic liver disease 3 2026-01-14
"A study in healthy people to test how 2 different formulations of a combination treatment (vicadrostat and empagliflozin) are taken up in … Ended

2025-521650-42-00 Healthy volunteer trial 3 2025-09-04
CK-0045 proof-of-concept study Ended

2024-514191-41-00 Type 2 diabetes and Obesity 4 2024-09-16
A Phase 2 Parallel Group Study in Adults with Type 2 Diabetes to evaluate Efficacy and Safety of GL0034 Ended

2024-513279-41-00 Type 2 diabetes mellitus 4 2024-09-06
Bioequivalence study of the oral suspension of netupitant/palonosetron combination product versus the hard capsules of netupitant/palonosetr… Ended

2023-504355-28-03 Healthy volunteers 2 2024-03-14
An open-label cocktail drug-drug interaction (DDI) clinical study to assess the effect of multiple oral dosing with leniolisib on the pharma… Ended

2023-507134-25-00 Activated Phosphoinositide 3-Kinase Delta Syndrome 3 2024-01-29
Safety and immune responses after vaccination with two investigational RNA-based vaccines against tuberculosis in healthy volunteers Ended

2023-509515-89-00 Tuberculosis 1 2023-04-14
A study to learn more about how safe nurandociguat is and how it affects the way the body processes rosuvastatin and dabigatran in healthy a… Ended

2025-524178-40-00 Chronic Kidney Disease 3